Business GrowthThe business momentum is considered positive, with GHC well positioned to benefit from the growing demand for healthcare in Italy.
Dividend PaymentsFor the first time, GHC has announced the payment of dividends, indicating a positive outlook for shareholders.
Financial PerformanceThe organic perimeter outperformed expectations and closed 2024 with solid growth driven by private patients and out-of-region patients, achieving an adjusted EBITDA margin of 19.3%.